Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

A key genomic subtype associated with lymphovascular invasion in invasive breast cancer.

Kurozumi S, Joseph C, Sonbul S, Alsaeed S, Kariri Y, Aljohani A, Raafat S, Alsaleem M, Ogden A, Johnston SJ, Aleskandarany MA, Fujii T, Shirabe K, Caldas C, Ashankyty I, Dalton L, Ellis IO, Desmedt C, Green AR, Mongan NP, Rakha EA.

Br J Cancer. 2019 Jun;120(12):1129-1136. doi: 10.1038/s41416-019-0486-6. Epub 2019 May 22.

PMID:
31114020
2.

Rho-GTPase activating-protein 18: a biomarker associated with good prognosis in invasive breast cancer.

Aleskandarany MA, Sonbul S, Surridge R, Mukherjee A, Caldas C, Diez-Rodriguez M, Ashankyty I, Albrahim KI, Elmouna AM, Aneja R, Martin SG, Ellis IO, Green AR, Rakha EA.

Br J Cancer. 2017 Oct 10;117(8):1176-1184. doi: 10.1038/bjc.2017.261. Epub 2017 Aug 22.

3.

Molecular Mechanisms Underlying Lymphovascular Invasion in Invasive Breast Cancer.

Aleskandarany MA, Sonbul SN, Mukherjee A, Rakha EA.

Pathobiology. 2015 Sep;82(3-4):113-23. doi: 10.1159/000433583. Epub 2015 Aug 31. Review.

4.

The role of lymphovascular invasion as a prognostic factor in patients with lymph node-positive operable invasive breast cancer.

Song YJ, Shin SH, Cho JS, Park MH, Yoon JH, Jegal YJ.

J Breast Cancer. 2011 Sep;14(3):198-203. doi: 10.4048/jbc.2011.14.3.198. Epub 2011 Sep 29.

5.

Mediator complex (MED) 7: a biomarker associated with good prognosis in invasive breast cancer, especially ER+ luminal subtypes.

Joseph C, Macnamara O, Craze M, Russell R, Provenzano E, Nolan CC, Diez-Rodriguez M, Sonbul SN, Aleskandarany MA, Green AR, Rakha EA, Ellis IO, Mukherjee A.

Br J Cancer. 2018 Apr;118(8):1142-1151. doi: 10.1038/s41416-018-0041-x. Epub 2018 Mar 28.

6.

Lymphovascular invasion is an independent predictor of survival in breast cancer after neoadjuvant chemotherapy.

Liu YL, Saraf A, Lee SM, Zhong X, Hibshoosh H, Kalinsky K, Connolly EP.

Breast Cancer Res Treat. 2016 Jun;157(3):555-64. doi: 10.1007/s10549-016-3837-5. Epub 2016 May 25.

7.

Clinicopathological and prognostic significance of Ras association and pleckstrin homology domains 1 (RAPH1) in breast cancer.

Kurozumi S, Joseph C, Sonbul S, Aleskandarany MA, Pigera M, Alsaleem M, Alsaeed S, Kariri Y, Nolan CC, Diez-Rodriguez M, Johnston S, Mongan NP, Fujii T, Shirabe K, Martin SG, Ellis IO, Green AR, Rakha EA.

Breast Cancer Res Treat. 2018 Nov;172(1):61-68. doi: 10.1007/s10549-018-4891-y. Epub 2018 Jul 28.

PMID:
30056565
8.

Lymphovascular invasion and histologic grade are associated with specific genomic profiles in invasive carcinomas of the breast.

Fidalgo F, Rodrigues TC, Pinilla M, Silva AG, Maciel Mdo S, Rosenberg C, de Andrade VP, Carraro DM, Krepischi AC.

Tumour Biol. 2015 Mar;36(3):1835-48. doi: 10.1007/s13277-014-2786-z. Epub 2014 Nov 13.

9.

Correlation of lymphovascular invasion with clinicopathological factors in invasive breast cancer: a meta-analysis.

Shen SD, Zhong SZ, Wang CZ, Huang WH.

Int J Clin Exp Med. 2015 Oct 15;8(10):17789-95. eCollection 2015.

10.

Prognostic Value of the Detection of Lymphovascular Invasion in Hormone Receptor-Positive Early Breast Cancer in the Era of Molecular Profiling.

Mutai R, Goldvaser H, Shochat T, Peretz I, Sulkes A, Yerushalmi R.

Oncology. 2019;96(1):14-24. doi: 10.1159/000492429. Epub 2018 Sep 25.

PMID:
30253418
11.

Lymphovascular invasion after neoadjuvant chemotherapy is strongly associated with poor prognosis in breast carcinoma.

Hamy AS, Lam GT, Laas E, Darrigues L, Balezeau T, Guerin J, Livartowski A, Sadacca B, Pierga JY, Vincent-Salomon A, Coussy F, Becette V, Bonsang-Kitzis H, Rouzier R, Feron JG, Benchimol G, LaƩ M, Reyal F.

Breast Cancer Res Treat. 2018 Jun;169(2):295-304. doi: 10.1007/s10549-017-4610-0. Epub 2018 Jan 27.

PMID:
29374852
12.

Saccharomyces cerevisiae-like 1 (SEC14L1) is a prognostic factor in breast cancer associated with lymphovascular invasion.

Sonbul SN, Aleskandarany MA, Kurozumi S, Joseph C, Toss MS, Diez-Rodriguez M, Nolan CC, Mukherjee A, Martin S, Caldas C, Ellis IO, Green AR, Rakha EA.

Mod Pathol. 2018 Nov;31(11):1675-1682. doi: 10.1038/s41379-018-0092-9. Epub 2018 Jun 28.

PMID:
29955149
13.

Preoperative prediction of lymphovascular invasion in invasive breast cancer with dynamic contrast-enhanced-MRI-based radiomics.

Liu Z, Feng B, Li C, Chen Y, Chen Q, Li X, Guan J, Chen X, Cui E, Li R, Li Z, Long W.

J Magn Reson Imaging. 2019 Feb 17. doi: 10.1002/jmri.26688. [Epub ahead of print]

PMID:
30773770
14.

The prognostic significance of STAT3 in invasive breast cancer: analysis of protein and mRNA expressions in large cohorts.

Aleskandarany MA, Agarwal D, Negm OH, Ball G, Elmouna A, Ashankyty I, Nuglozeh E, Fazaludeen MF, Diez-Rodriguez M, Nolan CC, Tighe PJ, Green AR, Ellis IO, Rakha EA.

Breast Cancer Res Treat. 2016 Feb;156(1):9-20. doi: 10.1007/s10549-016-3709-z. Epub 2016 Feb 23.

PMID:
26907764
15.

The molecular basis of breast cancer pathological phenotypes.

Heng YJ, Lester SC, Tse GM, Factor RE, Allison KH, Collins LC, Chen YY, Jensen KC, Johnson NB, Jeong JC, Punjabi R, Shin SJ, Singh K, Krings G, Eberhard DA, Tan PH, Korski K, Waldman FM, Gutman DA, Sanders M, Reis-Filho JS, Flanagan SR, Gendoo DM, Chen GM, Haibe-Kains B, Ciriello G, Hoadley KA, Perou CM, Beck AH.

J Pathol. 2017 Feb;241(3):375-391. doi: 10.1002/path.4847. Epub 2016 Dec 29.

16.

D2-40, Podoplanin, and CD31 as a Prognostic Predictor in Invasive Ductal Carcinomas of the Breast.

Lee JA, Bae JW, Woo SU, Kim H, Kim CH.

J Breast Cancer. 2011 Jun;14(2):104-11. doi: 10.4048/jbc.2011.14.2.104. Epub 2011 Jun 18.

17.

The prognostic significance of lymphovascular invasion in invasive breast carcinoma.

Rakha EA, Martin S, Lee AH, Morgan D, Pharoah PD, Hodi Z, Macmillan D, Ellis IO.

Cancer. 2012 Aug 1;118(15):3670-80. doi: 10.1002/cncr.26711. Epub 2011 Dec 16.

18.

A systematic review and meta-analysis of lymphovascular invasion in patients treated with radical cystectomy for bladder cancer.

Mari A, Kimura S, Foerster B, Abufaraj M, D'Andrea D, Gust KM, Shariat SF.

Urol Oncol. 2018 Jun;36(6):293-305. doi: 10.1016/j.urolonc.2018.03.018. Epub 2018 Apr 21. Review.

PMID:
29685374
19.
20.

Prognostic significance of lymphovascular invasion in colorectal cancer and its association with genomic alterations.

Jiang HH, Zhang ZY, Wang XY, Tang X, Liu HL, Wang AL, Li HG, Tang EJ, Lin MB.

World J Gastroenterol. 2019 May 28;25(20):2489-2502. doi: 10.3748/wjg.v25.i20.2489.

Supplemental Content

Support Center